CGRWX
Price
$31.74
Change
-$0.21 (-0.66%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

CGRWX vs RMFCX

Header iconCGRWX vs RMFCX Comparison
Open Charts CGRWX vs RMFCXBanner chart's image
Invesco Comstock Select A
Price$31.74
Change-$0.21 (-0.66%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
CGRWX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CGRWX vs. RMFCX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRWX is a Sell and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. CGRWX (797M). RMFCX pays higher dividends than CGRWX: RMFCX (1.69) vs CGRWX (1.44). CGRWX was incepted earlier than RMFCX: CGRWX (39 years) vs RMFCX (23 years). CGRWX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than CGRWX: RMFCX (250) vs CGRWX (1000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. CGRWX (0.65). RMFCX return over 5 years is better than : 40.39 vs. CGRWX (21.39).
CGRWXRMFCXCGRWX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence39 years23 years-
Gain YTD-0.34411.423-3%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets797M104B1%
Annual Yield % from dividends1.441.6985%
Returns for 1 year0.6512.635%
Returns for 3 years-0.5714.16-4%
Returns for 5 years21.3940.3953%
Returns for 10 years12.1861.8420%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc